David T. Omstead

Materials ScienceBiochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Engineering peptide-targeted liposomal nanoparticles optimized for improved selectivity for HER2-positive breast cancer cells to achieve enhanced in vivo efficacy”.

Engineering peptide-targeted liposomal nanoparticles optimized for improved selectivity for HER2-positive breast cancer cells to achieve enhanced in vivo efficacy

Journal of Controlled Release(2020)10.1016/j.jconrel.2020.04.010

N/A

0DataRank · unranked

75 citations

Jae-Ho Shin, Junmin Wu, David T. Omstead, Tanyel Kiziltepe, Laurie E. Littlepage +2 more

In vivo evaluation of CD38 and CD138 as targets for nanoparticle-based drug delivery in multiple myeloma

Journal of Hematology & Oncology(2020)10.1186/s13045-020-00965-4

N/A

0DataRank · unranked

38 citations

Franklin Mejia, Jenna Sjoerdsma, Baksun Kim, Jae-Ho Shin, Sabrina Khan +5 more

Combination non-targeted and sGRP78-targeted nanoparticle drug delivery outperforms either component to treat metastatic ovarian cancer

Journal of Controlled Release(2024)10.1016/j.jconrel.2024.09.014

N/A

0DataRank · unranked

7 citations

Emily K. Bromley, Jae-Ho Shin, Tyvette S. Hilliard, Yueying Liu, Caitlin Horgan +7 more